YAG laser system
Commercial- Indications
- Refractory angina
Company intelligence / Profile preview
CryoLife has commercialized several cardiovascular medical devices including preserved human cardiac/vascular tissues and surgical adhesives. Its SynerGraft® processed products are FDA-cleared for use in complex cardiac surgeries. The company’s BioGlue product has been used globally for aortic repair; a major clinical trial was recently conducted in China to support regulatory approval there.[2][6] Clinical results have shown improved outcomes in structural repair/hemostasis during surgery using their technologies.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CryoLife, Inc..